(Press-News.org) The disposable vapes ban in the UK could lead to young adults switching to alternative products, including cigarettes, new research led by the University of Bristol has found.
In response to rising concerns about youth vaping, the UK Government introduced a ban on disposable vapes last year (from 1 June 2025). While the ban was intended to curb underage use, its possible impact on around the 2.5 million adults in the UK who rely on disposable vapes is unclear.
The new qualitative research, published in PLOS Global Public Health today [11 March], sheds light on how young adults anticipated the ban might affect them. It is thought to be the first study to explore how people who used disposable vapes viewed the UK ban and how they expected to respond.
Researchers interviewed 22 regular disposable vape users aged 18–30, including people who had never-smoked, used to smoke, and dual-used vapes and cigarettes. Through online semi‑structured interviews, participants reflected on their vaping and smoking behaviours, how they expected to adapt post‑ban, and what wider effects they anticipated.
Key findings from the study include:
Strong support for the ban
Many participants expressed approval, linking the policy to the sharp rise in youth vaping.
Planned shift to reusable devices
A large proportion reported they would move to reusable or rechargeable vapes once disposables are no longer available.
Risk of increased smoking
Some dual-users, and a smaller number of never-regular smokers and one ex-smoker, said they might return to, or increase, cigarette smoking instead of switching to reusable vaping products.
Mixed views on illegal market effects
Several participants believed the ban would help reduce illegal sales, while others feared it could expand the illicit market for disposable vapes.
The study suggests that while the ban might achieve its intended benefits, particularly in reducing use among younger people, it could also lead to unintended consequences for young adult users. These include potential increases in cigarette smoking among some individuals.
Dr Jasmine Khouja, a researcher on the project while at the University of Bristol, who is now at the University of Bath, and one of the co-authors, said: “The disposable vape ban did not aim to encourage the use of cigarettes, other nicotine products, or illicit markets, yet some young adults considered these options in anticipation of the ban in June 2025.
“Our findings could help guide future research on the impacts of the disposable vape ban and inform efforts to reduce unintended consequences of the ban.”
Richie Carr, one of the study’s researchers and corresponding author, added: “Our study offers an important insight into how banning disposable vapes in the UK could affect young adult users. While many participants indicated they would switch to alternative vaping products, some said they might instead turn to cigarettes.”
The young adult sample provided a rich insight, but its makeup, mainly white females aged 18–22, with about half from the University of Bristol, limits how far the findings can be applied to other genders, ethnicities, and older adults.
The researchers suggest future research should explore how the ban affects a wider range of age groups using a more diverse participant group. Research should also objectively measure the impact of the implemented ban on behavioural changes such as smoking initiation, smoking frequency, use of other nicotine products, and illicit product use.
They also emphasise the need to identify and address potential mitigating factors to reduce unintended harms.
END
Disposable vapes ban could lead young adults to switch to cigarettes, study finds
2026-03-11
ELSE PRESS RELEASES FROM THIS DATE:
Adults with concurrent hearing and vision loss report barriers and challenges in navigating complex, everyday environments
2026-03-11
FOR IMMEDIATE RELEASE
According to a recent multi-institute PLOS One study led by the Multisensory Research Lab at the Wilmer Eye Institute, Johns Hopkins Medicine, time of hearing loss onset is a key determinant of patient confidence and self-reported sound localization abilities — the ability to perceive and locate objects in an environment — even in individuals who use hearing aids or who have received vision rehabilitation training.
The National Institutes of Health-supported study highlights factors that shape how people with dual sensory ...
Breast cancer stage at diagnosis differs sharply across rural US regions
2026-03-11
Key Takeaways
While women living in rural regions are known to face a higher risk of advanced breast cancer, a new analysis found that even within rural America, outcomes differ sharply based on region and other factors.
Women living in the South, Black and Hispanic women, and women without insurance are significantly more likely to be diagnosed with Stage 3 or 4 breast cancer.
Region-specific solutions, including rural surgeon training and targeted health policies, may help reduce disparities.
CHICAGO — Where a woman lives significantly affects whether ...
Concrete sensor manufacturer Wavelogix receives $500,000 grant from National Science Foundation
2026-03-11
WEST LAFAYETTE, Ind. — Wavelogix, a manufacturer of novel, patented concrete strength sensors invented at Purdue University’s College of Engineering, has received a $500,000 Small Business Innovation Research (SBIR) Phase IIB grant from the National Science Foundation’s (NSF) Directorate for Technology, Innovation and Partnerships.
The grant builds upon an SBIR Phase II grant awarded in 2024. The Phase IIB project is scheduled to end in December 2026.
Luna Lu, Wavelogix’s ...
California communities’ recovery time between wildfire smoke events is shrinking
2026-03-11
Californians have long dealt with wildfire smoke as a seasonal fact of life, but those fires have become more intense and frequent, raising the profile of wildfire smoke as a public health issue. Now, a study led by researchers at UC San Diego’s Scripps Institution of Oceanography finds that the time between multi-day smoke events is shrinking — leaving communities with less time to recover before smoke returns.
The new study, published March 11 in the journal GeoHealth, found that in California the window of cleaner air between smoke waves shrank by more than 60% from 2006 to 2020. The study also finds that ...
Augmented reality job coaching boosts performance by 79% for people with disabilities
2026-03-11
Employment can be a powerful gateway to independence, dignity and belonging. Yet for individuals with intellectual and developmental disabilities (IDD), that gateway remains limited. Although work supports better health, social connection and a sense of purpose, only about 15% of individuals with IDD are employed in competitive, integrated work settings.
This disparity persists despite federal programs like supported employment, which offers ongoing job coaching to help people with significant disabilities find and keep competitive jobs, and customized employment, which adapts job roles to match the strengths and needs of both employees and employers. This highlights a critical gap ...
Medical debt associated with deferring dental, medical, and mental health care
2026-03-11
Medical debt is associated with deferred dental care, medical care, and mental health care, even among people with health insurance, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
The study found that 42.3% of people with medical debt delayed dental care compared with 17.7% of those without—almost 2.4 times as many; 23.0% of people with medical debt delayed medical care compared with just 5.3% of those without—about 4.3 times as many; and 14% of people with medical ...
AAI appoints Anand Balasubramani as Chief Scientific Programs Officer
2026-03-11
The American Association of Immunologists (AAI) is pleased to announce the appointment of Anand Balasubramani, PhD, as its inaugural Chief Scientific Programs Officer (CSPO), effective March 25, 2026. This newly established executive role reflects AAI’s commitment to strengthening its scientific programming, expanding its thought leadership, and supporting the rapidly evolving field of immunology.
Dr. Balasubramani brings more than a decade of leadership experience in scientific publishing, program development, and ...
Prior authorization may hinder access to lifesaving heart failure medications
2026-03-11
Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two critical heart failure drugs, a new study shows.
Led by NYU Langone Health researchers, the analysis focused on angiotensin receptor-neprilysin inhibitors (ARNIs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are pillars of modern heart failure treatment. The drugs have no generic alternatives and can cost hundreds of dollars out of pocket. While they have been shown to substantially reduce the risk of death when added to standard therapy, ...
Scholars propose transparency, credit and accountability as key principles in scientific authorship guidelines
2026-03-11
Three principles - transparency, credit, and accountability – should form the foundation for “responsible authorship”, argues a working group comprising scholars, scientists and journal editors. In an article published March 10 in the Proceedings of the National Academy of Sciences (PNAS), the group, led by PLOS’ Chief Scientific Officer Veronique Kiermer, states that contributions worthy of authorship should be determined by who has accountability for the research, and that all who claim the credit implied by authorship must assume that accountability.
Who ...
Jeonbuk National University researchers develop DDINet for accurate and scalable drug-drug interaction prediction
2026-03-11
Managing complex medical conditions often requires the simultaneous use of multiple different drugs, referred to as polypharmacy. While necessary, this significantly increases the risk of drug–drug interactions (DDIs), which can either enhance or decrease therapeutic effects or trigger adverse drug reactions (ADRs), potentially leading to longer hospital stays or even life-threatening outcomes.
In recent years, researchers have increasingly turned to deep learning models to predict DDIs. Although these models often outperform traditional methods, they are usually tested under idealized conditions, in which training and test data are randomly split, failing to reflect real-world ...